2-171690205-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_001378.3(DYNC1I2):c.50G>A(p.Arg17Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000285 in 1,401,338 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000029 ( 0 hom. )
Consequence
DYNC1I2
NM_001378.3 missense
NM_001378.3 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 7.84
Genes affected
DYNC1I2 (HGNC:2964): (dynein cytoplasmic 1 intermediate chain 2) This gene encodes a member of the dynein intermediate chain family. The encoded protein is a non-catalytic component of the cytoplasmic dynein 1 complex, which acts as a retrograde microtubule motor to transport organelles and vesicles. A pseudogene of this gene is located on chromosome 10. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), DYNC1I2. . Gene score misZ 2.4516 (greater than the threshold 3.09). Trascript score misZ 3.3484 (greater than threshold 3.09). GenCC has associacion of gene with neurodevelopmental disorder with microcephaly and structural brain anomalies.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYNC1I2 | NM_001378.3 | c.50G>A | p.Arg17Gln | missense_variant | 2/18 | ENST00000397119.8 | NP_001369.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYNC1I2 | ENST00000397119.8 | c.50G>A | p.Arg17Gln | missense_variant | 2/18 | 1 | NM_001378.3 | ENSP00000380308.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000285 AC: 4AN: 1401338Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 691594
GnomAD4 exome
AF:
AC:
4
AN:
1401338
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
691594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.50G>A (p.R17Q) alteration is located in exon 2 (coding exon 1) of the DYNC1I2 gene. This alteration results from a G to A substitution at nucleotide position 50, causing the arginine (R) at amino acid position 17 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;T;.;T;.;.;T;.;T;.;.;T;T;T;.;.;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;M;M;.;M;M;.;M;M;.;M;.;.;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;D;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;T;D;D;D;D;D;D
Polyphen
1.0
.;D;D;.;.;D;D;.;D;D;.;.;.;.;.;.;.;.;.
Vest4
0.34, 0.35, 0.32, 0.30, 0.26, 0.33, 0.31
MutPred
Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);Gain of ubiquitination at K15 (P = 0.0472);
MVP
MPC
1.5
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at